ACT featured Ed Ikeguchi’s predictions in a stand-alone piece, “The Defining AI Trends of 2022,” illustrating the importance of working collaboratively and strategically to advance the adoption of digital biomarkers and the development of unbiased AI in driving precision medicine to inform personalized care.